Skip to main content
. Author manuscript; available in PMC: 2019 Mar 21.
Published in final edited form as: Nucl Receptor Res. 2018;5:101350. doi: 10.11131/2018/101350

Figure 3: SR1988 displays a receptor stabilisation profile typical of PPARγ partial agonists.

Figure 3:

HDX data for the corresponding peptides are plotted over the structures of PPARγ LBD bound to rosiglitazone (PDB 2PRG) and SR1988 (PDB: 6D3E). Percentage reduction (average of all replicates and all time points) in HDX relative to apo receptor is coloured according to the key. Residues are coloured to correspond to the average percent change in deuteration between apo and SR1988 or rosiglitazone bound PPARγ LBD.